The impact of the socioeconomic factor on Parkinson's disease medication adherence: a scoping review
Open Access
- 7 February 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (02) , 001-008
Abstract
Background Therapeutic adherence is a decisive issue on chronic disease management in patients requiring long-term pharmacotherapy, such as Parkinson's disease (PD). Although it is well known that socioeconomic factor is a barrier to medication adherence in many chronic diseases, its impacts on PD still need to be investigated. Objective Explore what and how socioeconomic factors impact medication adherence in people with PD. Methods We carried out a scoping review across three databases to identify studies exploring what and how socioeconomic factors impact medication adherence in people with PD considering eight attributes: 1. educational level, 2. disease-related knowledge, 3. income, 4. cost of medication, 5. drug subsidy (meaning presence of subsidies in the cost of medication), 6. employability, and 7. ethnicity (black, indigenous, immigrants). Results Of the 399 identified studies (Embase = 294, Medline = 88, LILACS = 17), eight met inclusion criteria. We identified factors covering the eight attributes of socioeconomic impact, and all of them negatively impacted the medication adherence of people with PD. The most prevalent factor in the studies was low patient educational level (four studies), followed by costs of medications (three studies), income (three studies), and disease-related knowledge (three studies). Distinctly from most of the studies selected, one of them evidenced suboptimal adherence in individuals receiving the medication free of charge, and another one could not find correlation between suboptimal adherence and educational level. Conclusion Socioeconomic factors negatively impact medication adherence in PD patients. This review provides basis for developing patient and population-based interventions to improve adherence to treatment in PD.Keywords
This publication has 39 references indexed in Scilit:
- Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s DiseaseClinical Therapeutics, 2013
- Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United StatesAnnals of Internal Medicine, 2012
- A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence ModelThe Journal of Clinical Hypertension, 2012
- Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON studyEuropean Journal of Neurology, 2010
- Adherence to antiparkinson medication in a multicenter European studyMovement Disorders, 2009
- Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trialBMC Neurology, 2007
- Adherence to MedicationNew England Journal of Medicine, 2005
- Suboptimal medication adherence in Parkinson's diseaseMovement Disorders, 2005
- Frequency, Reasons, and Risk Factors of Entacapone Discontinuation in Parkinson DiseaseClinical Neuropharmacology, 2004
- [Accessibility to the specific pharmacotherapy for Parkinson disease, in Santiago de Chile].1998